Gene · 3836
Papers2,991
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,991
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Distinct Mitotic Functions of Nucleolar and Spindle-Associated Protein 1 (NuSAP1) Are Controlled by Two Consensus SUMOylation Sites. | Cells | 2023 | 37947624 | PubTator, text mining | PubMed |
| Nuclear transport proteins: structure, function, and disease relevance. | Signal Transduct Target Ther | 2023 | 37945593 | PubTator, text mining | PubMed |
| XPOT Disruption Suppresses TNBC Growth through Inhibition of Specific tRNA Nuclear Exportation and TTC19 Expression to Induce Cytokinesis Failure. | Int J Biol Sci | 2023 | 37928256 | PubTator, text mining | PubMed |
| Retroviral hijacking of host transport pathways for genome nuclear export. | mBio | 2023 | 37909783 | PubTator, text mining | PubMed |
| Existing Evidence for Influenza B Virus Adaptations to Drive Replication in Humans as the Primary Host. | Viruses | 2023 | 37896807 | PubTator, text mining | PubMed |
| Double Heterozygosity for Rare Deleterious Variants in the BRCA1 and BRCA2 Genes in a Hungarian Patient with Breast Cancer. | Int J Mol Sci | 2023 | 37895014 | PubTator, text mining | PubMed |
| Evening Primrose Extract Modulates TYMS Expression via SP1 Transcription Factor in Malignant Pleural Mesothelioma. | Cancers (Basel) | 2023 | 37894370 | PubTator, text mining | PubMed |
| Nuclear Import and Export of YAP and TAZ. | Cancers (Basel) | 2023 | 37894323 | PubTator, text mining | PubMed |
| O-GlcNAcylation of MITF regulates its activity and CDK4/6 inhibitor resistance in breast cancer. | Res Sq | 2023 | 37886470 | PubTator, text mining | PubMed |
| Sugarcane streak mosaic virus P1 protein inhibits unfolded protein response through direct suppression of bZIP60U splicing. | PLoS Pathog | 2023 | 37883577 | PubTator, text mining | PubMed |
| Non-metabolic enzyme function of PKM2 in hepatocellular carcinoma: A review. | Medicine (Baltimore) | 2023 | 37861491 | PubTator, text mining | PubMed |
| The Nuclear Cap-Binding Complex, a multitasking binding partner of RNA polymerase II transcripts. | J Biochem | 2023 | 37830942 | PubTator, text mining | PubMed |
| Karyopherins in the Remodeling of Extracellular Matrix: Implications in Tendon Injury. | J Orthop Sports Med | 2023 | 37829147 | PubTator, text mining | PubMed |
| ABTB1 facilitates the replication of influenza A virus by counteracting TRIM4-mediated degradation of viral NP protein. | Emerg Microbes Infect | 2023 | 37823597 | PubTator, text mining | PubMed |
| Seneca Valley virus 3Cpro antagonizes type I interferon response by targeting STAT1-STAT2-IRF9 and KPNA1 signals. | J Virol | 2023 | 37819133 | PubTator, text mining | PubMed |
| Nuclear ERK1/2 signaling potentiation enhances neuroprotection and cognition via Importinα1/KPNA2. | EMBO Mol Med | 2023 | 37792911 | PubTator, text mining | PubMed |
| HECW2 promotes the progression and chemoresistance of colorectal cancer via AKT/mTOR signaling activation by mediating the ubiquitin-proteasome degradation of lamin B1. | J Cancer | 2023 | 37781079 | PubTator, text mining | PubMed |
| Nuclear translocation of thioredoxin-1 promotes colorectal cancer development via modulation of the IL-6/STAT3 signaling axis through interaction with STAT3. | Theranostics | 2023 | 37771783 | PubTator, text mining | PubMed |
| Hepatitis B Virus Epsilon (ε) RNA Element: Dynamic Regulator of Viral Replication and Attractive Therapeutic Target. | Viruses | 2023 | 37766319 | PubTator, text mining | PubMed |
| Prohibitin1 facilitates viral replication by impairing the RIG-I-like receptor signaling pathway. | J Virol | 2023 | 37754758 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3836/papers?page=8